Zimmer-Biomet Deal Clears EU Antitrust Review With Three Divestments
This article was originally published in The Gray Sheet
Executive Summary
Zimmer and Biomet will drop some knee and elbow product lines to satisfy European regulator concerns over its planned $13.35 billion merger.